Production and Use of Hymenolepis diminuta Cysticercoids as Anti-Inflammatory Therapeutics
AbstractHelminthic therapy has shown considerable promise as a means of alleviating some inflammatory diseases that have proven resistant to pharmaceutical intervention. However, research in the field has been limited by a lack of availability to clinician scientists of a helminth that is relatively benign, non-communicable, affordable, and effectively treats disease. Previous socio-medical studies have found that some individuals self-treating with helminths to alleviate various diseases are using the rat tapeworm (cysticercoid developmental stage of Hymenolepis diminuta; HDC). In this study, we describe the production and use of HDCs in a manner that is based on reports from individuals self-treating with helminths, individuals producing helminths for self-treatment, and physicians monitoring patients that are self-treating. The helminth may fit the criteria needed by clinical scientists for clinical trials, and the methodology is apparently feasible for any medical center to reproduce. It is hoped that future clinical trials using this organism may shed light on the potential for helminthic therapy to alleviate inflammatory diseases. Further, it is hoped that studies with HDCs may provide a stepping stone toward population-wide restoration of the biota of the human body, potentially reversing the inflammatory consequences of biota depletion that currently affect Western society. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Smyth, K.; Morton, C.; Mathew, A.; Karuturi, S.; Haley, C.; Zhang, M.; Holzknecht, Z.E.; Swanson, C.; Lin, S.S.; Parker, W. Production and Use of Hymenolepis diminuta Cysticercoids as Anti-Inflammatory Therapeutics. J. Clin. Med. 2017, 6, 98.
Smyth K, Morton C, Mathew A, Karuturi S, Haley C, Zhang M, Holzknecht ZE, Swanson C, Lin SS, Parker W. Production and Use of Hymenolepis diminuta Cysticercoids as Anti-Inflammatory Therapeutics. Journal of Clinical Medicine. 2017; 6(10):98.Chicago/Turabian Style
Smyth, Kendra; Morton, Claire; Mathew, Amanda; Karuturi, Sahil; Haley, Cliff; Zhang, Min; Holzknecht, Zoie E.; Swanson, Chelsea; Lin, Shu S.; Parker, William. 2017. "Production and Use of Hymenolepis diminuta Cysticercoids as Anti-Inflammatory Therapeutics." J. Clin. Med. 6, no. 10: 98.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.